Definium Therapeutics Announces New Employee Inducement Grants
Definium Therapeutics granted inducement options to purchase an aggregate of 93,320 shares to six newly hired non-executive employees, with grant dates of October 26, 2026. The options carry an exercise price equal to the closing price on the grant date and vest over four years, and were approved under NASDAQ Rule 5635(c)(4) pursuant to the company's 2026 Inducement Plan.
Key figures
- Vesting
- 4-year vest; 25% at first anniversary, remaining 75% monthly over three years
- Employees granted
- 6
- Options granted shares
- 93320
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.